|
1
|
Bieging KT, Mello SS and Attardi LD:
Unravelling mechanisms of p53-mediated tumour suppression. Nat Rev
Cancer. 14:359–370. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li T, Kon N, Jiang L, Tan M, Ludwig T,
Zhao Y, Baer R and Gu W: Tumor suppression in the absence of
p53-mediated cell-cycle arrest, apoptosis, and senescence. Cell.
149:1269–1283. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fitzmaurice C, Dicker D, Pain A, Hamavid
H, Moradi-Lakeh M, MacIntyre MF, Allen C, Hansen G, Woodbrook R,
Wolfe C, et al Global Burden of Disease Cancer Collaboration: The
Global Burden of Cancer 2013. JAMA Oncol. 1:505–527. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bailey CE, Hu CY, You YN, Bednarski BK,
Rodriguez-Bigas MA, Skibber JM, Cantor SB and Chang GJ: Increasing
disparities in the age-related incidences of colon and rectal
cancers in the United States, 1975–2010. JAMA Surg. 150:17–22.
2015. View Article : Google Scholar :
|
|
5
|
Fearon ER and Vogelstein B: A genetic
model for colorectal tumorigenesis. Cell. 61:759–767. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Leslie A, Carey FA, Pratt NR and Steele
RJ: The colorectal adenoma-carcinoma sequence. Br J Surg.
89:845–860. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Munro AJ, Lain S and Lane DP: P53
abnormalities and outcomes in colorectal cancer: A systematic
review. Br J Cancer. 92:434–444. 2005.PubMed/NCBI
|
|
8
|
Russo A, Bazan V, Iacopetta B, Kerr D,
Soussi T and Gebbia N; TP53-CRC Collaborative study Group: The TP53
colorectal cancer international collaborative study on the
prognostic and predictive significance of p53 mutation: Influence
of tumor site, type of mutation, and adjuvant treatment. J Clin
Oncol. 23:7518–7528. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Krieg AJ, Hammond EM and Giaccia AJ:
Functional analysis of p53 binding under differential stresses. Mol
Cell Biol. 26:7030–7045. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hammond EM, Mandell DJ, Salim A, Krieg AJ,
Johnson TM, Shirazi HA, Attardi LD and Giaccia AJ: Genome-wide
analysis of p53 under hypoxic conditions. Mol Cell Biol.
26:3492–3504. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tanikawa C, Zhang YZ, Yamamoto R, Tsuda Y,
Tanaka M, Funauchi Y, Mori J, Imoto S, Yamaguchi R, Nakamura Y, et
al: The transcriptional landscape of p53 signalling pathway.
EBioMedicine. 20:109–119. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sharma M, Giridharan SS, Rahajeng J,
Naslavsky N and Caplan S: MICAL-L1 links EHD1 to tubular recycling
endosomes and regulates receptor recycling. Mol Biol Cell.
20:5181–5194. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Funauchi Y, Tanikawa C, Yi Lo PH, Mori J,
Daigo Y, Takano A, Miyagi Y, Okawa A, Nakamura Y and Matsuda K:
Regulation of iron homeostasis by the p53-ISCU pathway. Sci Rep.
5:164972015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ueda K, Ishikawa N, Tatsuguchi A, Saichi
N, Fujii R and Nakagawa H: Antibody-coupled monolithic silica
microtips for highthroughput molecular profiling of circulating
exosomes. Sci Rep. 4:62322014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kanda Y: Investigation of the freely
available easy-to-use software 'EZR' for medical statistics. Bone
Marrow Transplant. 48:452–458. 2013. View Article : Google Scholar
|
|
16
|
el-Deiry WS, Kern SE, Pietenpol JA,
Kinzler KW and Vogelstein B: Definition of a consensus binding site
for p53. Nat Genet. 1:45–49. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tanikawa C, Matsuda K, Fukuda S, Nakamura
Y and Arakawa H: p53RDL1 regulates p53-dependent apoptosis. Nat
Cell Biol. 5:216–223. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mori J, Tanikawa C, Funauchi Y, Lo PH,
Nakamura Y and Matsuda K: Cystatin C as a p53-inducible apoptotic
mediator that regulates cathepsin L activity. Cancer Sci.
107:298–306. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Miyamoto T, Lo PHY, Saichi N, Ueda K,
Hirata M, Tanikawa C and Matsuda K: Argininosuccinate synthase 1 is
an intrinsic Akt repressor transactivated by p53. Sci Adv.
3:e16032042017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Giridharan SS, Cai B, Vitale N, Naslavsky
N and Caplan S: Cooperation of MICAL-L1, syndapin2, and
phosphatidic acid in tubular recycling endosome biogenesis. Mol
Biol Cell. 24:1776–1790. S1–15. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rahajeng J, Giridharan SS, Cai B,
Naslavsky N and Caplan S: MICAL-L1 is a tubular endosomal membrane
hub that connects Rab35 and Arf6 with Rab8a. Traffic. 13:82–93.
2012. View Article : Google Scholar :
|
|
22
|
Conn PM: Methods in Enzymology G protein
coupled receptors trafficking and oligomerization. Preface Methods
Enzymol. 521. pp. xix2013, View Article : Google Scholar
|
|
23
|
Sigismund S, Confalonieri S, Ciliberto A,
Polo S, Scita G and Di Fiore PP: Endocytosis and signaling: Cell
logistics shape the eukaryotic cell plan. Physiol Rev. 92:273–366.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yu X, Riley T and Levine AJ: The
regulation of the endosomal compartment by p53 the tumor suppressor
gene. FEBS J. 276:2201–2212. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Crighton D, Wilkinson S, O'Prey J, Syed N,
Smith P, Harrison PR, Gasco M, Garrone O, Crook T and Ryan KM:
DRAM, a p53-induced modulator of autophagy, is critical for
apoptosis. Cell. 126:121–134. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li YM, Pan Y, Wei Y, Cheng X, Zhou BP, Tan
M, Zhou X, Xia W, Hortobagyi GN, Yu D, et al: Upregulation of CXCR4
is essential for HER2-mediated tumor metastasis. Cancer Cell.
6:459–469. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Caswell PT, Spence HJ, Parsons M, White
DP, Clark K, Cheng KW, Mills GB, Humphries MJ, Messent AJ, Anderson
KI, et al: Rab25 associates with alpha5beta1 integrin to promote
invasive migration in 3D microenvironments. Dev Cell. 13:496–510.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jović M, Kieken F, Naslavsky N, Sorgen PL
and Caplan S: Eps15 homology domain 1-associated tubules contain
phosphatidylinositol-4-phosphate and
phosphatidylinositol-(4,5)-bisphosphate and are required for
efficient recycling. Mol Biol Cell. 20:2731–2743. 2009. View Article : Google Scholar
|
|
29
|
Suzuki T, Nakamoto T, Ogawa S, Seo S,
Matsumura T, Tachibana K, Morimoto C and Hirai H: MICAL, a novel
CasL interacting molecule, associates with vimentin. J Biol Chem.
277:14933–14941. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Reinecke JB, Katafiasz D, Naslavsky N and
Caplan S: Novel functions for the endocytic regulatory proteins
MICAL-L1 and EHD1 in mitosis. Traffic. 16:48–67. 2015. View Article : Google Scholar
|
|
31
|
Cormont M, Metón I, Mari M, Monzo P,
Keslair F, Gaskin C, McGraw TE and Le Marchand-Brustel Y: CD2AP/CMS
regulates endosome morphology and traffic to the degradative
pathway through its interaction with Rab4 and c-Cbl. Traffic.
4:97–112. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Dikic I: CIN85/CMS family of adaptor
molecules. FEBs Lett. 529:110–115. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Abou-Zeid N, Pandjaitan R, Sengmanivong L,
David V, Le Pavec G, Salamero J and Zahraoui A: MICAL-like1
mediates epidermal growth factor receptor endocytosis. Mol Biol
Cell. 22:3431–3441. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bist A, Fielding CJ and Fielding PE: p53
regulates caveolin gene transcription, cell cholesterol, and growth
by a novel mechanism. Biochemistry. 39:1966–1972. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Amson RB, Nemani M, Roperch JP, Israeli D,
Bougueleret L, Le Gall I, Medhioub M, Linares-Cruz G, Lethrosne F,
Pasturaud P, et al: Isolation of 10 differentially expressed cDNAs
in p53-induced apoptosis: Activation of the vertebrate homologue of
the drosophila seven in absentia gene. Proc Natl Acad Sci USA.
93:3953–3957. 1996. View Article : Google Scholar : PubMed/NCBI
|
